Mineralys Therapeutics, Inc. (MLYS)
24.07
+0.79
(+3.39%)
USD |
NASDAQ |
Mar 20, 16:00
24.06
-0.01
(-0.04%)
After-Hours: 20:00
Mineralys Therapeutics Shareholders Equity (Quarterly) : 646.69M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 738.98M |
| Nektar Therapeutics | 89.83M |
| Syndax Pharmaceuticals, Inc. | 64.63M |
| Cogent Biosciences, Inc. | 636.37M |
| Lyell Immunopharma, Inc. | 248.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 661.81M |
| Total Liabilities (Quarterly) | 15.11M |
| Current Ratio | 43.76 |